• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Exploratory study on the development of novel therapy targeting.-glutamyl transpeptidase

Research Project

Project/Area Number 21592328
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Morphological basic dentistry
Research InstitutionHiroshima University

Principal Investigator

MIYAUCHI Mutsumi  広島大学, 医歯薬学総合研究科, 准教授 (50169265)

Co-Investigator(Kenkyū-buntansha) TAKATA Takashi  広島大学, 大学院・医歯薬学総合研究科, 教授 (10154783)
KITAGAWA Masae  広島大学, 病院, 助教 (10403627)
Co-Investigator(Renkei-kenkyūsha) NIIDA Syunpei  国立長寿医療研究センター, 室長 (10137630)
Project Period (FY) 2009 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Keywordsγ-glutamyl transpeptidase / 慢性肝疾患 / 二次性骨粗鬆症 / 抗体治療 / 骨量減少 / 破骨細胞性骨吸収 / 骨芽細胞分化 / 歯周炎 / γ-GTP / 骨破壊 / 歯周病 / 骨粗鬆症 / 治療薬 / 抗体 / γGTP / 骨破壞
Research Abstract

Cholestatic liver diseases often manifest the increased levels of γ- glutamyl transpeptidase(GGT) and secondary osteoporosis. GGT is known as a novel bone resorbing factor that stimulates osteoclast formation. The aim of this study was to elucidate the mechanisms by which GGT causes bone reduction.
In BDL rats with elevation of serum GGT level, bone reduction with increase of osteoclasts was evident. These changes were significantly attenuated by AGT3. In vitro study showed significant upregulation of osteoclastogenesis via osteoblasts and inhibition of osteoblast differentiation with GGT stimulation. Moreover upregulation of GGT in periodontal tissue induced alveolar bone destruction with osteoclastogenesis, whereas antibody treatment reduced it. Therefore managing the elevated GGT by AGT3 may become a novel therapeutic agent for secondary osteoporosis and periodontitis in cholestatic liver diseases.

Report

(4 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • 2009 Annual Research Report
  • Research Products

    (9 results)

All 2010 2009

All Presentation (9 results)

  • [Presentation] γ-glutamyl transpeptidase (GGT) is a potent risk factor of periodontitis2010

    • Author(s)
      Mutsumi Miyauchi, Yusuke Kawazoe, Takashi Takata
    • Organizer
      第58回国際歯科研究学会日本部会 (JADR) 総会・学術大会
    • Place of Presentation
      北九州市(日本)
    • Year and Date
      2010-11-20
    • Related Report
      2010 Annual Research Report
  • [Presentation] hyper-γ-glutamyl transpeptidase(GGT) emia is a potent risk factor forosteoporosis2010

    • Author(s)
      Miyauchi M, Kawazoe Y, Inubushi T, Takata T.
    • Organizer
      The 15th InternationalCongress of Oral Pathology and Medicine
    • Place of Presentation
      Souel, KOREA
    • Related Report
      2011 Final Research Report
  • [Presentation] glutamyl transpeptidase(GGT) is apotent risk factor of periodontitis2010

    • Author(s)
      Miyauchi M, Kawazoe Y, Takata T.
    • Organizer
      58th JADR Annual Meeting
    • Place of Presentation
      Kitakyusyu, JAPAN
    • Related Report
      2011 Final Research Report
  • [Presentation] hyper-γ-glutamyl transpeptidase (GGT)emia is a potent risk factor for osteoporosis2010

    • Author(s)
      Mutsumi Miyauchi, Yusuke Kawazoe, Takashi Takata
    • Organizer
      The 15th International Congress of Oral Pathology and Medicine
    • Place of Presentation
      Seoul (韓国)
    • Related Report
      2010 Annual Research Report
  • [Presentation] 高γ-glutamyl transpeptidase 血症が骨破壊に及ぼす影響について2009

    • Author(s)
      宮内睦美
    • Organizer
      第20回日本臨床口腔病理学会総会・学術大会
    • Place of Presentation
      札幌市
    • Year and Date
      2009-07-30
    • Related Report
      2009 Annual Research Report
  • [Presentation] Influence of elevation ofGGT by cholestatic liver disease on boneand LPS induced alveolar bone destruction2009

    • Author(s)
      Kawazoe Yusuke, Miyauchi Mutsumi, Takata Takashi
    • Organizer
      3rd The International Workshop onBiodental education & Research
    • Place of Presentation
      Hiroshima JAPAN
    • Related Report
      2011 Final Research Report
  • [Presentation] Elevation of・-gulutamyl transpeptidasewith cholestatic liver diseases is apotential risk factor of osteoporosis andperiodontal disease2009

    • Author(s)
      Takata T, Kawazoe Y, Miyauchi M, NiidaS.
    • Organizer
      32nd The AnnualScientific Meeting of the Association forDental Sciences of the Republic of China
    • Place of Presentation
      Takao TAIPEI
    • Related Report
      2011 Final Research Report
  • [Presentation] 歯肉溝滲出液中γ-グルタミルトランスペプチダーゼ活性を用いた歯周診断システムの構築の可能性について2009

    • Author(s)
      川添祐亮, 宮内睦美, 古庄寿子, 新飯田俊平, 高田隆
    • Organizer
      第52回日本歯周病学会春季学術大会
    • Place of Presentation
      岡山市
    • Related Report
      2011 Final Research Report
  • [Presentation] 高γ-glutamyltranspeptidase血症が骨破壊に及ぼす影響について2009

    • Author(s)
      宮内睦美, 川添祐亮, 古庄寿子, 新飯田俊平, 高田隆.
    • Organizer
      第20回日本臨床口腔病理学会総会・学術大会
    • Place of Presentation
      札幌市
    • Related Report
      2011 Final Research Report

URL: 

Published: 2009-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi